In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.

Autor: Abastabar M; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Zaedi A; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Shabanzadeh S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Nosratabadi M; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Moazeni M; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Aghili SR; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Haghani I; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Khojasteh S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Javidnia J; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Nargesi S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Shokohi T; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Hedayati MT; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Meis JF; Department of Medical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; ECMM Excellence Center for Medical Mycology, Centre of Expertise in Mycology Radboudumc/Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands., Badali H; Department of Molecular Microbiology & Immunology, South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, USA.

Publikováno v: Mycoses [Mycoses] 2022 Nov; Vol. 65 (11), pp. 981-988. Date of Electronic Publication: 2022 Jun 30.

Economic Evaluation of Denosumab for Treatment of Postmenopausal Osteoporosis: A Systematic Review

Autor: Nargesi, S., Barghazan, S. H., Sani Ee, N., Kemmak, A. R.

Publikováno v: Scopus-Elsevier

Background: We aimed to review the systematic economic evaluation of denosumab versus than alternative drugs and oral bisphosphonates of postmenopausal osteoporosis in women and help health system policy makers for prioritizing and optimally allocate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60f6cd982aad9c953a526a76770d87c9
https://pubmed.ncbi.nlm.nih.gov/36248303

A Whole Genome Sequencing-Based Approach to Track down Genomic Variants in Itraconazole-Resistant Species of Aspergillus from Iran.

Autor: Nargesi S; Department of Medical Mycology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari 4815733971, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari 4815733971, Iran., Valadan R; Department of Immunology/Molecular and Cell Biology Research Center (MCBRC), Mazandaran University of Medical Sciences, Sari 48175-1665, Iran., Abastabar M; Department of Medical Mycology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari 4815733971, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari 4815733971, Iran., Kaboli S; Department of Medical Biotechnology, School of Medicine, Zanjan University of Medical Sciences, Zanjan 4513956111, Iran.; Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan 4513956111, Iran., Thekkiniath J; Fuller Laboratories, 1312 East Valencia Drive, Fullerton, CA 92831, USA., Hedayati MT; Department of Medical Mycology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari 4815733971, Iran.; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari 4815733971, Iran.

Publikováno v: Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2022 Oct 17; Vol. 8 (10). Date of Electronic Publication: 2022 Oct 17.

Development of RFLP method for rapid differentiation of Aspergillus flavus and Aspergillus oryzae, two species with high importance in clinical and food microbiology.

Autor: Abastabar M; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: mabastabar@gmail.com., Shabanzadeh S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Valadan R; Molecular and Cell Biology Research Center (MCBRC), Mazandaran University of Medical Sciences, Sari, Iran., Mayahi S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Haghani I; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Khojasteh S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Nargesi S; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran., Seyedmousavi S; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran; Microbiology Service, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States., Hedayati MT; Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Invasive Fungi Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Electronic address: hedayatimt@gmail.com.

Publikováno v: Journal de mycologie medicale [J Mycol Med] 2022 Aug; Vol. 32 (3), pp. 101274. Date of Electronic Publication: 2022 Mar 09.

Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review.

Autor: Nargesi S; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Science, Tehran, Iran., Dolatshahi Z; Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran., Rezapour A; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Science, Tehran, Iran., Alipour V; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Science, Tehran, Iran., Souresrafil A; Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran., Farabi H; Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran., Javadmoosavi SA; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Science, Tehran, Iran., Safakhah M; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Science, Tehran, Iran., Moradi N; Health Management and Economics Research Center, Health Management Research Institute, Iran University of Medical Science, Tehran, Iran.

Publikováno v: Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Jun; Vol. 22 (4), pp. 543-554. Date of Electronic Publication: 2021 Dec 12.